| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |